22nd century group vp of regulatory science to participate in fdli panel in response to recent fda action on comprehensive plan and reduced nicotine mandate

Buffalo, n.y., oct. 13, 2021 (globe newswire) -- 22nd century group, inc. (nasdaq: xxii), a leading agricultural biotechnology company focused on tobacco harm reduction, reduced nicotine tobacco, and health and wellness through plant science, announced today that the company's vice president of regulatory science, john pritchard, was invited and will participate as a panelist at the food and drug law institute (fdli) tobacco and nicotine products regulation and policy conference as part of the event's session, “reactor panel: assessing the past, present, and future of the comprehensive plan,” on wednesday, october 27, 2021, at 11:55 a.m. et. the session will consider key points of the u.s. food and drug administration's (fda) center for tobacco products director, mitch zeller's keynote address, and the current state of and future directions for fda's comprehensive plan for product regulation, in particular the mandate to make all cigarettes “minimally or non-addictive.”
XXII Ratings Summary
XXII Quant Ranking